Genomics in Primary Care: What Clinicians Need to Know (Virtual)

Genomics in Primary Care: What Clinicians Need to Know (Virtual)
The session PGx Mantara is promotional and has been organised by Mantara. CliniLink have been not involved in the design, content, or delivery of this promotional session.

£0.00

Please log in to book this webinar

WEBINAR

THIS EVENT IS OPEN TO UK REGISTERED HEALTHCARE PROFESSIONALS ONLY

Location: Microsoft Teams


Event Agenda

Time Topic Speaker
19:00-19:05 Welcome And Introduction CliniLink
19:05-19:20PGx Mantara. This session is promotional and has been organised by Mantara. CliniLink has not been involved in the design, content, or delivery of this promotional session.. Dr Mark J. Hudson-Peacock
19:20-20:20A concise, practical overview of how genomics is shaping everyday primary care, with real-world examples covering risk assessment, medicines optimisation and referral decision-making for UK clinicians. Dr Mark J. Hudson-Peacock
20:20-21:00Q&ADr Mark J. Hudson-Peacock

Why Should Healthcare Professionals Attend?

Genomics is rapidly moving from specialist services into everyday primary care practice. From inherited cancer risk to pharmacogenomics and referral decisions, clinicians are increasingly expected to recognise when genetics matters — and act confidently.

This session, delivered by Dr Mark J. Hudson-Peacock, provides a concise, practical overview of how genomics is shaping modern primary care. Using real-world clinical examples, the webinar will simplify complex concepts and demonstrate how genomics can support safer prescribing, better risk assessment, and more informed referral decisions for UK clinicians.

Learning Objectives

By the end of this session, participants will be able to:

  • Recognise when genomic considerations are relevant in primary care consultations.

  • Apply basic principles of risk assessment for inherited conditions.

  • Understand the role of pharmacogenomics in medicines optimisation.

  • Identify appropriate referral pathways for genetic services in the UK.

Key Benefits

  • Practical, real-world application of genomics in everyday consultations

  • Improved confidence in medicines optimisation decisions

  • Clearer understanding of referral thresholds and red flags

  • Enhanced patient conversations around risk and family history

  • CPD-accredited learning suitable for revalidation portfolios

Additional Information

  • CPD certificates will be issued to all attendees.

  • The joining link will be available via your Clinilink account (please ensure you are logged in to access it).

  • Suitable for GPs, prescribing pharmacists, nurses, and wider primary care MDT members.


Meet the Speaker

Dr Mark J Hudson-Peacock

BSc (Hons), MBBCh,FRCP,MIoD. Consultant Dermatologist & CMO, The Dermatology Partnership
Dr Mark Hudson-Peacock is an entrepreneur and the co-founder/Chairman and Medical Director of the eXroid group of companies and founder/Chairman and Medical Director of Mantara Health Ltd.

He launched the first commercially available Pharmacogenomics (PGx) test in the UK, which has full MHRA registration and CE and UKCA marks. With a passion for therapeutics, he aims to drive safer prescribing through evidence-based, affordable PGx products.

Understanding that around 90% of medications only work in 30–50% of patients, Dr Hudson-Peacock advocates personalised medicine using simple saliva tests to generate individual medication reports, improving patient outcomes and sustainability by reducing ineffective prescribing.

Event Partners

The session PGx Mantara is promotional and has been organised by Mantara. CliniLink has not been involved in the design, content, or delivery of this promotional session.

Upcoming Events